Medspacedaily

  Sales of face masks are climbing in Sweden…. The Royal Academy of Sciences said on Tuesday that face masks could play a role in reducing infection and urged Sweden politicians to rethink their decision not to recommend their citizens the use of face masks amid a second wave of infections. Obviously, Sweden's previous soft-touch pandemic response had not prevented the increasingly spread of the virus and new cases of the virus recently hitting record levels. Hence, the country has taken tough measures to control this climb in covid-19 cases by reducing public gathering maximum up to eight people. Certain Reports claim that Face Masks provides pseudo sense of being completely secure from the virus infection and people do not think about to avoid unnecessary social gatherings, which may have been one of the bigger reason of significant rise in covid-19 cases in Sweden and in other part of the world.   "I hope there is now a debate and leaders, irrespective of wh...

 Government of India has now allowed Post graduate doctors of Ayurveda to practice legally in the field of General surgery with ENT, orthopedics and dentistry. The central government of India has made an amendment to the Indian medicine central council regulations (IMCCR), 2016 for the introduction of these mentioned specialities curriculum for PG courses of "Shalya" and "Shalakya" Specializations of Ayurveda and will be issued titles of MS(Ayurveda) Shalya Tantra for General Surgery and MS (Ayurveda) Shalakya Tantra for ENT, Ortho and Dentistry. Hence, The Indian Medical Association (IMA) has openly opposed this constant policy change by the Government Of India and demanded to withdrawal of the notification of amendment regulations of postgraduate Ayurveda Education. National President of IMA, DR. Rajat Sharma said that this integration of systems of medicine would creat "Khichdi Medical System" and produce the "Hybrid Doctors". The apex bod...

After Nearly seven months waiting, we finally have the good news: Two big companies leading the race for COVID-19 vaccine have released promising results from their Phase 3 trials. Pfizer and the German biotechnology company BioNTech  announced early findings of their vaccine, BNT162b2 and  Moderna, a Cambridge, Massachusetts-based biotechnology company, mRNA-1273. final results for both are expected as soon as in few weeks. Pfizer released the preliminary result that it's candidate vaccine was more than 95% effective while Moderna’s vaccine appears to be 94.5% effective. Both of the results stand the text of time. Both candidate vaccines reported mild or moderate side effects, mostly pain at the injection site, fatigue and aching of muscles and joints for a day or two. The Moderna and Pfizer vaccines are based on delivering strands of genetic material to turn people’s cells into factories of spike protein, which was found on the surface of the virus. Then the body sees the p...

The first COVID-19 test kit has been given emergency authorization by US Food And Drug Administration (FDA) for home use on Tuesday. As we already have the good news from two vaccine production companies, among them Pfizer Inc vaccine which is 90% effective and Moderna Inc is 94.5% effective which has given hope to fight the situation much better, this testing kit is an add on factor to that. This kit is developed by Lucira Health, which is a single use testing kit which can be used with Nasal Swabs collected by individuals who're suspected of being positive for COVID-19 disease by their family doctor. the person's age should be 14 or more than that. the kit can also be used at health centers and hospitals where the samples must be collected by healthcare providers if the age of individual is less than of 14 year old. Jeff Shuren, the director of FDA Center for Devices and Radiological Health said, "We look forward to proactively working with test developers to support th...